Cerebral Palsy (CP)VET-PEDNCT07793032
Experimental Validation of the Virtual Eggs Test (VET) in the Pediatric Population
A study testing Virtual Eggs Test (VET) in people with Cerebral Palsy (CP) and Developmental Coordination Disorder (DCD), run by IRCCS Fondazione Stella Maris at 1 site in Italy.
Trial summary
This study aims to investigate the validity of the Virtual Egg Test (VET) for the assessment of manual dexterity in children and adolescents with cerebral palsy and developmental coordination disorder (experimental group), including a typically developing group for the collection and establishment of normative values… Read more about this study
- Who is it for?
- Ages 6 to 21 yearsHealthy volunteers can take part
- Conditions the study is for
- Cerebral Palsy (CP), Developmental Coordination Disorder (DCD)
- What is being tested?
- Virtual Eggs Test (VET)
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 130 participants
- Where
- 1 siteItaly
- Study dates
- 1 Sep 2026to 30 Nov 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 6 to 21 years
- All sexes
- Healthy volunteers accepted
- Child, Adult
Who may be able to join
- Diagnosis of Cerebral Palsy;
- Participants of either sex and of any ethnicity, aged between 6 and 21 years at the time of recruitment;
- MACS Level I-III (for participants with Cerebral Palsy);
- BFMF Level I-IV (for participants with Cerebral Palsy);
- House Functional Classification Level 4-8;
- At least one cognitive index score >70 on the WISC-IV, WISC-V, or WAIS-IV;
Show all 17Show fewer
- Participants who have provided informed consent, or for whom the legal guardian has provided informed consent and acknowledged receipt of the study information sheet.
- Inclusion Criteria - Developmental Coordination Disorder Group
- Diagnosis of Developmental Coordination Disorder;
- Participants of either sex and of any ethnicity, aged between 6 and 21 years at the time of recruitment;
- Total mABC-2 score below the 15th percentile;
- At least one cognitive functioning index score not lower than 2 standard deviations below the population mean, assessed using standardized tests performed within the previous 12 months, in order to ensure sufficient ability to understand and cooperate with the proposed activities;
- Participants who have provided informed consent, or for whom the legal guardian has provided informed consent and acknowledged receipt of the study information sheet.
- Participants of either sex and of any ethnicity, aged between 6 and 21 years;
- Green zone on the mABC-2 Checklist;
- Participants with cognitive and language abilities adequate to understand the experiment and follow instructions;
- Participants who have provided informed consent, or for whom the legal guardian has provided informed consent and acknowledged receipt of the study information sheet.
Who cannot join
- Exclusion Criteria - Cerebral Palsy and Developmental Coordination Disorder Groups
- Participants with evident visual or oculomotor impairments;
- Concomitant general or localized comorbidities/disabilities (e.g., multiple sclerosis, Parkinson's disease, muscle tone disorders, malignant neoplasms, etc.) that may interfere with the ability to understand and perform the study protocol;
- Presence of pathological cardiopulmonary or cardiovascular conditions;
- Pregnancy or breastfeeding;
- Insufficient level of cooperation.
Show all 12Show fewer
- Participants with evident visual or oculomotor impairments;
- Concomitant general or localized comorbidities/disabilities (e.g., multiple sclerosis, Parkinson's disease, muscle tone disorders, malignant neoplasms, etc.) that may interfere with the ability to understand and perform the study protocol;
- Presence of pathological cardiopulmonary or cardiovascular conditions;
- Pregnancy or breastfeeding;
- Presence of psychiatric comorbidities;
- Insufficient level of cooperation.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Italy1 site
IRCCS Fondazione Stella Maris
Calambrone, Pisa, 56128
Giuseppina Sgandurra, PhD, MD, 050886284, giuseppina.sgandurra@fsm.unipi.it
About this study
Official title: Experimental Validation of the Virtual Eggs Test (VET) in Children and Young Adults With Cerebral Palsy and Developmental Coordination Disorder
This study aims to investigate the validity of the Virtual Egg Test (VET) for the assessment of manual dexterity in children and adolescents with cerebral palsy and developmental coordination disorder (experimental group), including a typically developing group for the collection and establishment of normative values (control group).
The clinical site where the study procedures for the experimental group will be conducted is the IRCCS Fondazione Stella Maris in Calambrone (Pisa), Italy. Participants of both sexes and of any ethnicity, aged between 6 and 21 years at the time of recruitment, will be selected according to specific inclusion criteria.
Read more
The study protocol consists of two assessment sessions scheduled at an interval of at least 3 days and no more than 5 days.
During the first assessment session (T0), standardized and non-standardized assessment procedures will be administered. First, the Virtual Egg Test (VET) will be administered using the Virtual Egg (VE). The VE is a parallelepiped-shaped device equipped with an internal magnetic mechanism that maintains the walls of the object in a predefined, non-collapsed position. When the grip force exceeds the attractive force between the two magnets, the external walls move closer together, causing the "VE to break" reversibly.
The sensorized platform comprises three distinct sensitive areas: the starting position and two target areas for placing the VEs. The areas are separated by a 6-cm-high barrier.
Subsequently, standardized clinical assessment tests will be administered. During the second assessment session (T1), the Virtual Egg Test (VET) will be administered, followed by a feasibility questionnaire specifically developed for this study regarding its use. The questionnaire will be completed by both the participant and the clinical staff.
- Being tested
- Virtual Eggs Test (VET)
- Keywords
- VET, Cerebral Palsy, developmental coordination disorder, manual dexterity
- Medical subject headings
- Cerebral Palsy, Motor Skills Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Virtual Eggs Test (VET)Device
The clinical study consists of one enrollment session and two testing sessions, scheduled 3-5 days apart for both the control group and participants with Cerebral Palsy or Developmental Coordination Disorder. During enrollment, eligibility is assessed and informed consent is obtained, and participant profiling data are collected. The first testing session varies by population. Control participants perform the Virtual Eggs Test (VET) with both dominant and non-dominant hands. Participants with Cerebral Palsy undergo the VET, Box and Block Test, Tyneside Pegboard Test, ABILHAND-Kids, and Monofilament Test. Participants with Developmental Coordination Disorder undergo the VET, Box and Block Test, Tyneside Pegboard Test, DCDQ'07, SDQ, Conners 3 Self-Report Scale, and Monofilament Test. The VET is always administered first. The second testing session consists exclusively of the VET with both hands, following the same administration order as the first session.
| Study group | Role | What they receive |
|---|---|---|
| Arm 1: Typically Developing Participants | Experimental | A total of 80 participants aged 6-21 years with typical development will be recruited. Participants will be stratified by age and sex, with at least five females and five males recruited for each of the following age groups: 6-7, 8-9, 10-11, 12-13, 14-15, 16-17, 18-19, and 20-21 years.
All participants will perform the Virtual Egg Test (VET) during two testing sessions, scheduled 3 or 5 days apart. Receives: Device: Virtual Eggs Test (VET) |
| Arm 2: Participants with Cerebral Palsy or Developmental Coordination Disorder | Experimental | A total of 50 participants aged 6-21 years with Cerebral Palsy or Developmental Coordination Disorder will be recruited. Participants will be distributed across the following age groups, irrespective of sex: 6-7, 8-9, 10-11, 12-13, 14-15, 16-17, 18-19, and 20-21 years.
Participants will perform the Virtual Egg Test (VET) during two testing sessions, scheduled 3 or 5 days apart. Receives: Device: Virtual Eggs Test (VET) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Score of Virtual Eggs Test (VET)
The Virtual Eggs Test (VET) is a medical device for assessing fine and gross dexterity by analyzing the participant's ability to carry fragile objects.
The main components of the VET are a set of fragile objects, called Virtual Eggs (VEs), a sensorized platform used to guide task execution, and software developed to support the therapist in data acquisition.
The VET execution protocol includes two phases: a familiarization phase and a testing phase. The goal of the first phase is to make the participant familiar with the movements to be performed. During the testing phase, participants are asked to carry the selected VEs from one point on the platform to another (passing the barrier) without breaking them and as quickly as possible. At the end of the test, the VET provides a fine dexterity index and a gross dexterity index by combining information regarding the speed of transport of the VEs and the accuracy of grip force regulation.
Measured: Baseline (VET test) and 3-5 days after baseline (VET retest)
Secondary outcomes (7)
Score of Box and Blocks Test (BBT)
The Box and Block Test (BBT) measures unilateral manual dexterity. The BBT consists of a wooden box divided into two compartments by a barrier and 150 blocks. The test involves asking the patient to move, one by one, the maximum number of blocks from one compartment of the box to the other, within 60 seconds. Higher scores on the test indicate better gross manual dexterity.
This standardized test has also been validated for pediatric use and is used widely in clinical practice among assessment tests for upper limb performance in children with neurodevelopmental disorders and disabilities, such as CP.
Measured: At baseline
Score of Tyneside Pegboard Test (TPT)
The Tyneside Pegboard Test (TPT) is a test for measuring fine manual dexterity in children with unilateral CP. During the test, participants are asked to insert nine pegs into a pegboard as quickly as possible. Based on the tests available in the literature for assessing manual dexterity, the TPT can quantitatively measure, in terms of time, manual dexterity in children with hand motor impairment, such as children with unilateral CP. A faster execution time indicates greater fine motor skills.
Measured: At baseline
Score of ABILHAND-Kids (only for children with CP)
Is a brief questionnaire that measures 21 key bimanual daily activities. The score is assigned by a parent based on the difficulty the child has in performing the requested activity on a daily basis, using a 3-point scale (impossible, difficult, easy). The response scores are entered into a Rasch model to obtain a continuous score representing the child's level of manual ability. A higher score indicates greater manual skill and autonomy.
It has been validated in children with Cerebral Palsy aged 6 to 15 years, showing good validity (R=0.94) and good reproducibility over time (R=0.91).
Only participants of CP group will be tested with ABILHAND-Kids.
Measured: At baseline
Score of Semmes Weinstein monofilament test
Sensory perception is evaluated with the Semmes-Weinstein monofilaments which are designed to exert specific amounts of force when applied to the skin. They come in various sizes, each representing a different level of force or pressure. During the examination, the therapist will apply the monofilaments to the distal phalanx index of each hand and the participant will be asked to indicate whether they can feel the monofilament, with vision occluded. The score is based on the three correct trials of the last monofilament applied. A lower monofilament stimulus intensity indicates better sensory perception.
This measure was introduced to assess tactile perception of children with CP, as it is often associated with the motor impairment typical of children with this diagnostic profile.
Measured: At baseline
Score of Motor Coordination Questionnaire (DCDQ'07) (for children with DCD)
The Motor Coordination Questionnaire (DCDQ) is a measurement tool for parents, developed to help identify Motor Coordination Disorder (DCD) in children, aged 5 to 15 years. Parents are asked to compare their child's motor performance with that of their peers, using a 5-point Likert scale. The questionnaire provides a standardized method for measuring a child's motor coordination in daily activities. The internal consistency of the DCDQ is high and the results from discriminant function analyses were appropriately strong for a screening tool. Only participants of DCD group will be tested with DCDQ.
Measured: At baseline
Score of Strength and Difficulties Questionnaire (SDQ) (only for children with DCD)
This is a rather concise instrument that provides a wealth of information about a child's behavior. It contains 25 items that refer to positive or negative attributes of the child's behavior. The items are divided into 5 subscales: hyperactivity, conduct problems, emotional difficulties, prosocial behavior, and peer relationships. The same questionnaire can be completed by both teachers and parents, to assess children between the ages of 4 and 16. The evaluator uses a 3-point Likert scale to indicate how descriptive a given attribute is of the child's behavior.
On the four scales describing negative behaviors, a higher score corresponds to more severe difficulties. On the Prosocial Behavior scale, a higher score indicates more positive behaviors Only participants of DCD group will be tested with SDQ.
Measured: At baseline
Score of Conners 3- Self-Report Scale (only for children with DCD)
An assessment tool used to identify and analyze behaviors and symptoms associated with behavior and attention disorders in children.
Being a self-completed questionnaire, it provides important information about how the child behaves in all situations, not just at home or at school.
The questionnaire consists of both content and syndrome subscales, with raw scores transformed to age- and gender-normed T-scores (mean = 50, SD = 10). Higher scores are indicative of greater problems, with scores between 60 and 69 considered "elevated" and scores above 70 "very elevated." Only participants of DCD group will be tested with Conners 3- Self-Report Scale.
Measured: At baseline
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted28 Aug 2026
- Study start1 Sep 2026 (estimated)
- Primary completion30 Nov 2026 (estimated)
- Study completion30 Nov 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (9)Papers the sponsor has linked to this study.
- Other trials for Cerebral Palsy (CP)Studies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 130 participants (estimated)
Sponsor and investigators
- Lead sponsor
- IRCCS Fondazione Stella Maris
- Sponsor type
- University, hospital or other
- Collaborators
- Scuola Superiore Sant'Anna di Studi Universitari e di Perfezionamento
- Responsible party
- Principal investigator, Giuseppina Sgandurra, IRCCS Fondazione Stella Maris
- Investigators
- Giuseppina Sgandurra, PhD, MD, Principal investigator, IRCCS Fondazione Stella Maris
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07793032
- Sponsor's protocol ID
- VET-PED
- Acronym
- VET-PED
- Status last verified
- Aug 2026
- First submitted
- 18 Aug 2026
- Last updated
- 28 Aug 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Publications
Mathiowetz V, Volland G, Kashman N, Weber K. Adult norms for the Box and Block Test of manual dexterity. Am J Occup Ther. 1985 Jun;39(6):386-91. doi: 10.5014/ajot.39.6.386.
PubMed 3160243Liang KJ, Chen HL, Huang KL, Wang TM, Shieh JY, Wang TN. Assessment for Tactile Perception in Children With Cerebral Palsy. Am J Occup Ther. 2023 Jul 1;77(4):7704205050. doi: 10.5014/ajot.2023.050106.
PubMed 37624995Auld ML, Ware RS, Boyd RN, Moseley GL, Johnston LM. Reproducibility of tactile assessments for children with unilateral cerebral palsy. Phys Occup Ther Pediatr. 2012 May;32(2):151-66. doi: 10.3109/01942638.2011.652804. Epub 2012 Feb 7.
PubMed 22309074Krumlinde-Sundholm L, Eliasson AC. Comparing tests of tactile sensibility: aspects relevant to testing children with spastic hemiplegia. Dev Med Child Neurol. 2002 Sep;44(9):604-12. doi: 10.1017/s001216220100264x.
PubMed 12227615Jongbloed-Pereboom M, Nijhuis-van der Sanden MW, Steenbergen B. Norm scores of the box and block test for children ages 3-10 years. Am J Occup Ther. 2013 May-Jun;67(3):312-8. doi: 10.5014/ajot.2013.006643.
PubMed 23597689Basu AP, Kirkpatrick EV, Wright B, Pearse JE, Best KE, Eyre JA. The Tyneside Pegboard Test: development, validation, and observations in unilateral cerebral palsy. Dev Med Child Neurol. 2018 Mar;60(3):314-321. doi: 10.1111/dmcn.13645. Epub 2017 Dec 16.
PubMed 29247458Arnould C, Penta M, Renders A, Thonnard JL. ABILHAND-Kids: a measure of manual ability in children with cerebral palsy. Neurology. 2004 Sep 28;63(6):1045-52. doi: 10.1212/01.wnl.0000138423.77640.37.
PubMed 15452296Controzzi M, Angelini L, Randi P, Mucci P, Mazzeo A, Ferrari R, Gruppioni E, Cipriani C. Assessing Hand Function in Trans-Radial Amputees Wearing Myoelectric Hands: The Virtual Eggs Test (VET). IEEE Trans Neural Syst Rehabil Eng. 2024 Dec 31;PP. doi: 10.1109/TNSRE.2024.3524791. Online ahead of print.
PubMed 40030773Clemente F, D'Alonzo M, Controzzi M, Edin BB, Cipriani C. Non-Invasive, Temporally Discrete Feedback of Object Contact and Release Improves Grasp Control of Closed-Loop Myoelectric Transradial Prostheses. IEEE Trans Neural Syst Rehabil Eng. 2016 Dec;24(12):1314-1322. doi: 10.1109/TNSRE.2015.2500586. Epub 2015 Nov 13.
PubMed 26584497
Study at a glance
From the registry record, last updated by the sponsor on 28 Aug 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Experimental Validation of the Virtual Eggs Test (VET) in Children and Young Adults With Cerebral Palsy and Developmental Coordination Disorder
- ClinicalTrials.gov ID
- NCT07793032
- Acronym / sponsor ID
- VET-PED / VET-PED
- Keywords
- VET, Cerebral Palsy, developmental coordination disorder, manual dexterity
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 130 participants (estimated)
- Lead sponsor
- IRCCS Fondazione Stella MarisUniversity, hospital or other
- Collaborators
- Scuola Superiore Sant'Anna di Studi Universitari e di Perfezionamento
- Study start
- 1 Sep 2026 (estimated)
- Primary completion
- 30 Nov 2026 (estimated)
- Study completion
- 30 Nov 2026 (estimated)
- First posted
- 28 Aug 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to investigate the validity of the Virtual Egg Test (VET) for the assessment of manual dexterity in children and adolescents with cerebral palsy and developmental coordination disorder (experimental group), including a typically developing group for the collection and establishment of normative values (control group).
The clinical site where the study procedures for the experimental group will be conducted is the IRCCS Fondazione Stella Maris in Calambrone (Pisa), Italy. Participants of both sexes and of any ethnicity, aged between 6 and 21 years at the time of recruitment, will be selected according to specific inclusion criteria.
The study protocol consists of two assessment sessions scheduled at an interval of at least 3 days and no more than 5 days.
During the first assessment session (T0), standardized and non-standardized assessment procedures will be administered. First, the Virtual Egg Test (VET) will be administered using the Virtual Egg (VE). The VE is a parallelepiped-shaped device equipped with an internal magnetic mechanism that maintains the walls of the object in a predefined, non-collapsed position. When the grip force exceeds the attractive force between the two magnets, the external walls move closer together, causing the "VE to break" reversibly.
The sensorized platform comprises three distinct sensitive areas: the starting position and two target areas for placing the VEs. The areas are separated by a 6-cm-high barrier.
Subsequently, standardized clinical assessment tests will be administered. During the second assessment session (T1), the Virtual Egg Test (VET) will be administered, followed by a feasibility questionnaire specifically developed for this study regarding its use. The questionnaire will be completed by both the participant and the clinical staff.
Study design
- Primary purpose
- Other
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Arm 1: Typically Developing Participants | Experimental | Device: Virtual Eggs Test (VET)A total of 80 participants aged 6-21 years with typical development will be recruited. Participants will be stratified by age and sex, with at least five females and five males recruited for each of the following age groups: 6-7, 8-9, 10-11, 12-13, 14-15, 16-17, 18-19, and 20-21 years. All participants will perform the Virtual Egg Test (VET) during two testing sessions, scheduled 3 or 5 days apart. |
| Arm 2: Participants with Cerebral Palsy or Developmental Coordination Disorder | Experimental | Device: Virtual Eggs Test (VET)A total of 50 participants aged 6-21 years with Cerebral Palsy or Developmental Coordination Disorder will be recruited. Participants will be distributed across the following age groups, irrespective of sex: 6-7, 8-9, 10-11, 12-13, 14-15, 16-17, 18-19, and 20-21 years. Participants will perform the Virtual Egg Test (VET) during two testing sessions, scheduled 3 or 5 days apart. |
Who may qualify
- Ages
- 6 to 21 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult
Key inclusion criteria (17 listed)
- Diagnosis of Cerebral Palsy;
- Participants of either sex and of any ethnicity, aged between 6 and 21 years at the time of recruitment;
- MACS Level I-III (for participants with Cerebral Palsy);
- BFMF Level I-IV (for participants with Cerebral Palsy);
- House Functional Classification Level 4-8;
Key exclusion criteria (12 listed)
- Exclusion Criteria - Cerebral Palsy and Developmental Coordination Disorder Groups
- Participants with evident visual or oculomotor impairments;
- Concomitant general or localized comorbidities/disabilities (e.g., multiple sclerosis, Parkinson's disease, muscle tone disorders, malignant neoplasms, etc.) that may interfere with the ability to understand and perform the study protocol;
- Presence of pathological cardiopulmonary or cardiovascular conditions;
- Pregnancy or breastfeeding;
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Virtual Eggs Test (VET)The clinical study consists of one enrollment session and two testing sessions, scheduled 3-5 days apart for both the control group and participants with Cerebral Palsy or Developmental Coordination Disorder. During enrollment, eligibility is assessed and informed consent is obtained, and participant profiling data are collected. The first testing session varies by population. Control participants perform the Virtual Eggs Test (VET) with both dominant and non-dominant hands. Participants with Cerebral Palsy undergo the VET, Box and Block Test, Tyneside Pegboard Test, ABILHAND-Kids, and Monofilament Test. Participants with Developmental Coordination Disorder undergo the VET, Box and Block Test, Tyneside Pegboard Test, DCDQ'07, SDQ, Conners 3 Self-Report Scale, and Monofilament Test. The VET is always administered first. The second testing session consists exclusively of the VET with both hands, following the same administration order as the first session. | Device | Arm 1: Typically Developing Participants, Arm 2: Participants with Cerebral Palsy or Developmental Coordination Disorder |
Primary outcome
Score of Virtual Eggs Test (VET)
Time frame: Baseline (VET test) and 3-5 days after baseline (VET retest)
The Virtual Eggs Test (VET) is a medical device for assessing fine and gross dexterity by analyzing the participant's ability to carry fragile objects. The main components of the VET are a set of fragile objects, called Virtual Eggs (VEs), a sensorized platform used to guide task execution, and software developed to support the therapist in data acquisition. The VET execution protocol includes two phases: a familiarization phase and a testing phase. The goal of the first phase is to make the participant familiar with the movements to be performed. During the testing phase, participants are asked to carry the selected VEs from one point on the platform to another (passing the barrier) without breaking them and as quickly as possible. At the end of the test, the VET provides a fine dexterity index and a gross dexterity index by combining information regarding the speed of transport of the VEs and the accuracy of grip force regulation.
7 secondary outcomes
Score of Box and Blocks Test (BBT)
Time frame: At baseline
Score of Tyneside Pegboard Test (TPT)
Time frame: At baseline
Score of ABILHAND-Kids (only for children with CP)
Time frame: At baseline
Score of Semmes Weinstein monofilament test
Time frame: At baseline
Score of Motor Coordination Questionnaire (DCDQ'07) (for children with DCD)
Time frame: At baseline
Score of Strength and Difficulties Questionnaire (SDQ) (only for children with DCD)
Time frame: At baseline
Score of Conners 3- Self-Report Scale (only for children with DCD)
Time frame: At baseline
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 28 Aug 2026.
- Background: PubMed 3160243Mathiowetz V, Volland G, Kashman N, Weber K. Adult norms for the Box and Block Test of manual dexterity. Am J Occup Ther. 1985 Jun;39(6):386-91. doi: 10.5014/ajot.39.6.386.
- Background: PubMed 37624995Liang KJ, Chen HL, Huang KL, Wang TM, Shieh JY, Wang TN. Assessment for Tactile Perception in Children With Cerebral Palsy. Am J Occup Ther. 2023 Jul 1;77(4):7704205050. doi: 10.5014/ajot.2023.050106.
- Background: PubMed 22309074Auld ML, Ware RS, Boyd RN, Moseley GL, Johnston LM. Reproducibility of tactile assessments for children with unilateral cerebral palsy. Phys Occup Ther Pediatr. 2012 May;32(2):151-66. doi: 10.3109/01942638.2011.652804. Epub 2012 Feb 7.
- Background: PubMed 12227615Krumlinde-Sundholm L, Eliasson AC. Comparing tests of tactile sensibility: aspects relevant to testing children with spastic hemiplegia. Dev Med Child Neurol. 2002 Sep;44(9):604-12. doi: 10.1017/s001216220100264x.
- Background: PubMed 23597689Jongbloed-Pereboom M, Nijhuis-van der Sanden MW, Steenbergen B. Norm scores of the box and block test for children ages 3-10 years. Am J Occup Ther. 2013 May-Jun;67(3):312-8. doi: 10.5014/ajot.2013.006643.
- Background: PubMed 29247458Basu AP, Kirkpatrick EV, Wright B, Pearse JE, Best KE, Eyre JA. The Tyneside Pegboard Test: development, validation, and observations in unilateral cerebral palsy. Dev Med Child Neurol. 2018 Mar;60(3):314-321. doi: 10.1111/dmcn.13645. Epub 2017 Dec 16.
- Background: PubMed 15452296Arnould C, Penta M, Renders A, Thonnard JL. ABILHAND-Kids: a measure of manual ability in children with cerebral palsy. Neurology. 2004 Sep 28;63(6):1045-52. doi: 10.1212/01.wnl.0000138423.77640.37.
- Background: PubMed 40030773Controzzi M, Angelini L, Randi P, Mucci P, Mazzeo A, Ferrari R, Gruppioni E, Cipriani C. Assessing Hand Function in Trans-Radial Amputees Wearing Myoelectric Hands: The Virtual Eggs Test (VET). IEEE Trans Neural Syst Rehabil Eng. 2024 Dec 31;PP. doi: 10.1109/TNSRE.2024.3524791. Online ahead of print.
- Background: PubMed 26584497Clemente F, D'Alonzo M, Controzzi M, Edin BB, Cipriani C. Non-Invasive, Temporally Discrete Feedback of Object Contact and Release Improves Grasp Control of Closed-Loop Myoelectric Transradial Prostheses. IEEE Trans Neural Syst Rehabil Eng. 2016 Dec;24(12):1314-1322. doi: 10.1109/TNSRE.2015.2500586. Epub 2015 Nov 13.
Related trials for Cerebral Palsy (CP)
Not yet recruitingObservational study
Turkish Translation, Cross-Cultural Adaptation, Validity, and Reliability of the ABILHAND-Kids Young CP Scale
Cerebral Palsy
Not yet recruiting
Ayres Sensory Integration Intervention for Children With Cerebral Palsy
Cerebral Palsy (CP)
Recruiting
Repetitive Transcranial Magnetic Stimulation on Motor Function and Meta-Plasticity in Cerebral Palsy: TMS-EEG Study
Cerebral Palsy, Typically Developing Children
RecruitingPhase 1
Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cell Intravenous Infusion for CP
Cerebral Palsy
Active, not recruiting
Virtual Reality Vs Postural Control Training in Children With Cerebral Palsy
Children With Hemiplegic cp
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Giuseppina Sgandurra, PhD, MD principal investigator
IRCCS Fondazione Stella Maris
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Virtual Eggs Test (VET) in people with Cerebral Palsy (CP) and Developmental Coordination Disorder (DCD), run by IRCCS Fondazione Stella Maris at 1 site in Italy.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 17 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 28 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Giuseppina Sgandurra, PhD, MD (+39 050886284, giuseppina.sgandurra@fsm.unipi.it), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Score of Virtual Eggs Test (VET) (time frame: Baseline (VET test) and 3-5 days after baseline (VET retest)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07793032, which also lists 9 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Aug 2026.